[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349248-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349248-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","application-of-dendritic-cell-extracellular-vesicles-as-a-valid-nanoparticle-platform-for-cancer-therapies-narrative-review","Application of Dendritic Cell Extracellular Vesicles as a Valid Nanoparticle Platform for Cancer Therapies - narrative review","","Cancer prevalence has increased over the past decades, and cancer remains a leading cause of global mortality. Although modern immunotherapies can improve survival, new modalities are required for better outcomes. Extracellular vesicles (EVs) provide cell-free nanoscale platforms that may reduce risks and side effects. Dendritic cell EVs, as antigen-presenting-cell derived bioshuttles, transfer immunogenic molecules and help process antigens with co-regulatory factors to guide immune responses. Engineered DC EV technologies aim to enhance tumor-targeted immunotherapeutic potential through advanced delivery and scalable production.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/application-of-dendritic-cell-extracellular-vesicles-as-a-valid-nanoparticle-platform-for-cancer-therapies-narrative-review/349248/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/application-of-dendritic-cell-extracellular-vesicles-as-a-valid-nanoparticle-platform-for-cancer-therapies-narrative-review/349248.png","ImageObject",300,407,{"name":42,"@type":43},"eBook King","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are extracellular vesicles (EVs) considered useful in cancer immunotherapy?","Question",{"text":63,"@type":64},"EVs are nanosized particles used for cell-free approaches rather than direct whole-cell administration, which may help reduce risks and side effects of immunotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role do dendritic cell extracellular vesicles (DC EVs) play in immune regulation?",{"text":68,"@type":64},"DC EVs transfer immunogenic molecules and antigens with co-regulatory factors to immune cell subsets, supporting the control of immune responses in a paracrine manner.",{"name":70,"@type":61,"acceptedAnswer":71},"How do engineered DC EVs aim to improve cancer therapy outcomes?",{"text":72,"@type":64},"Recent technologies enable engineered DC EVs with higher immunotherapeutic potential, supporting tumor-killing properties and development of improved delivery systems while enabling large-scale production.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349248,1790798290,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":107,"preview_urls":147},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Nezamdoust etal. Stem Cell Research & Therapy (2026) 17:206 [https://doi.org/10.1186/s13287-026-05011-7](https://doi.org/10.1186/s13287-026-05011-7)  \nStem Cell Research & Therapy  \nREVIEW Open Access  \nApplication of dendritic cell extracellular vesicles as a valid nanoparticle platform for cancer therapies: a narrative review  \nFereshteh Vaziri Nezamdoust 1,2, Parinaz Nezhad-Mokhtari3, Behnaz Mirzaahmadi4, Zeinab Mazloumi5, Parisa Kangari5 and Reza Rahbarghazi 1,2*  \nAbstract  \nThe prevalence of cancers has actually increased during the last few decades, affecting almost all human societies. Despite progress in therapeutic protocols, cancer is still the main cause of global human mortality. Although the advancement of modern immunotherapeutic approaches can increase the survival rate of cancer patients, new modalities are essential for improved therapeutic outcomes. Extracellular vesicles (EVs) are nanosized particles and are used for cell-free approaches instead of direct whole cell-based administration. It has been thought that EVscan reduce the risks and side effects of immunotherapy. Dendritic cells (DCs), belonging to antigen-presenting cells (APCs), are present in different parts of the body with the fundamental activity against tumors and various inflammatory conditions. Due to the existence of reconfigurable contents, DC EVs are valid bioshuttles to transfer immunogenic molecules, process antigens along with co-regulatory factors to other immune cell subsets like T lymphocytes, involved in the control of immune responses in a paracrine manner. Besides, recent technologies have enabled us to produce engineered DC EVs with higher immunotherapeutic potential against the tumor cells. In the current review article, we aimed to discuss recent developments in nanomedicine and biotechnology fields for the application of DC EVs in terms of cancer. The recent data will help the researchers and clinicians to understand the underlying mechanism associated with the tumoricidal properties of DC EVs and the development of a new delivery system in cancer conditions. Besides, the application of sophisticated modalities and technologies can help in the large-scale production of engineered DC EVs for the alleviation of cancer-related pathologies in the clinical setting with high-rate regenerative outcomes.  \nKeywords Dendritic cells, Extracellular vesicles, Tumors, Engineering methods, Nanomedicine  \n*Correspondence:  \nReza Rahbarghazi  \n[rezarahbardvm@gmail.com](rezarahbardvm@gmail.com); [rahbarghazir@tbzmed.ac.ir](rahbarghazir@tbzmed.ac.ir)  \n1Department of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran  \n2Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran  \n3Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran  \n4Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran  \n5Stem Cell and Regenerative Medicine Institute (SCARM), Tabriz University of Medical Sciences, Tabriz, Iran  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use,","cbCaikrYeUNp8thC","https://ap.wps.com/l/cbCaikrYeUNp8thC","pdf",7154567,62,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"Why are extracellular vesicles (EVs) considered useful in cancer immunotherapy?\",\"answer\":\"EVs are nanosized particles used for cell-free approaches rather than direct whole-cell administration, which may help reduce risks and side effects of immunotherapy.\"},{\"question\":\"What role do dendritic cell extracellular vesicles (DC EVs) play in immune regulation?\",\"answer\":\"DC EVs transfer immunogenic molecules and antigens with co-regulatory factors to immune cell subsets, supporting the control of immune responses in a paracrine manner.\"},{\"question\":\"How do engineered DC EVs aim to improve cancer therapy outcomes?\",\"answer\":\"Recent technologies enable engineered DC EVs with higher immunotherapeutic potential, supporting tumor-killing properties and development of improved delivery systems while enabling large-scale production.\"}]","Application of Dendritic Cell Extracellular Vesicles as a Valid Nanoparticle Platform for Cancer Therapies - narrative review | PDF",1790082434,156,[148,152,156,160,164,168,172],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19e8406db8604e975122e8d33a130ef5.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b04375352a103554029de09b6ae614f.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37072446ab2dadc08d837cec29482c33.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be0d903fdeb44c8035dd533baa58118a.webp",980,1306,{"page_no":97,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3ae87ae2002a741b3c2436a5f80c468.webp",979,1305,{"page_no":102,"url":169,"width":170,"height":171},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4769c4396948860f6c7d59b63ecb5d96.webp",978,1304,{"page_no":107,"url":173,"width":174,"height":175},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a34af09514e8a86834feeb268471566.webp",977,1302]